anonymous
Guest
anonymous
Guest
The reps make 155K base plus 50K bonus.
Little to no access. They log 7 F2F calls per day.
Little to no access. They log 7 F2F calls per day.
We’ll, if access sucks do bad, it ain’t going to last even the year!No BS. It’s completely True. The Syneos/Evusheld Reps base pay is 155K with a target bonus of 50K.
Complete package equals 205K Yearly. Not too bad.
The access sucks!!!
Complete bullshit post. They be lucky to be clearing $100k salary, more like $70-85k range
Why do we even have a contract sales force to begin with. I mean the drug is not brain surgery so we could learn it easily. Just like any other medication!
I hope those positions are the spots for the unfortunate people during the holidays who get displaced
Seriously, just STFU. You have no idea what are are talking about. Moron.Evusheld side effects are worse than Covid! MI, coagulation, HF, death... those SAEs were are the lower dose! Zero safety studies on the double dose! Why would anyone prescribe this?
EvuSheld is going nowhere. Hospitals are not buying it for various operational issues as to which area it should be given in. Base is $75/$80 for Syneos reps who all came from selling prior Moncolonal Antibody contract and they flipped the salesforce. Now the Syneos salesforce will all be jumping ship for the Ashfield Pfizer Monoclonal Antibody contract - better pay better ($80-$90K) and better indications for patient population and this therapy has the best clinical outcomes. Looks like Pfizer has won in the MA category.
please don’t add your input if you dont actually know. These reps make 150k+ in base, they all get a standard 50k bonus- that’s across the board, nobody even has to use it to get it.